CRISPR interference (CRISPRi) is a technique that uses an engineered CRISPR system to reduce gene expression by directing a DNA-binding protein to a selected genetic sequence. In its most common form, a catalytically inactive Cas9 protein, called dCas9, associates with a guide RNA and binds a target site in DNA without cutting it. This binding can obstruct transcription directly or position an attached repressor near a gene’s regulatory region. Unlike conventional nuclease-based genome editing, CRISPRi generally changes gene activity rather than the underlying DNA sequence.
Terminology and origins
In natural CRISPR immune systems, interference refers to the stage in which CRISPR-associated proteins recognize and act against foreign nucleic acids. These systems occur in bacteria and archaea and can defend against agents such as bacteriophages. Depending on the CRISPR system, natural interference can involve cleavage of DNA or RNA.
In experimental gene regulation, however, CRISPR interference usually means the engineered transcriptional-repression technique abbreviated CRISPRi. This meaning should be distinguished from the broader natural immune process.
The modern CRISPRi approach was introduced in 2013 by Lei S. Qi and colleagues, who demonstrated that catalytically inactive Cas9 could be programmed to repress transcription without cleaving DNA. Work reported that year by Luke A. Gilbert and colleagues also established the use of CRISPR-associated proteins as platforms for recruiting transcriptional regulatory domains in eukaryotic cells. Subsequent developments improved repression strength, guide selection, and compatibility with large-scale genetic screens.
Molecular mechanism
Programmable DNA binding
A standard CRISPRi system contains two principal components:
- A DNA-binding effector, usually dCas9, whose DNA-cleaving activities have been disabled.
- A guide RNA, which specifies the target sequence through complementary base pairing.
For the widely used Cas9 from Streptococcus pyogenes, the guide typically contains a targeting segment of about 20 nucleotides. DNA recognition also requires an adjacent protospacer-adjacent motif (PAM), usually NGG for this Cas9. Other Cas proteins and engineered variants have different requirements.
The guide RNA directs dCas9 to a complementary DNA sequence, where the complex forms a stable DNA-bound structure. Because the catalytic sites are inactive, binding does not normally produce the targeted double-strand break associated with active Cas9. The bound complex instead serves as a physical obstacle or as an anchor for regulatory proteins.
Direct obstruction of transcription
In bacteria, dCas9 alone can strongly repress transcription. Binding near a promoter can prevent RNA polymerase from initiating transcription. Binding within a transcribed region can obstruct elongation.
Repression depends on target position, local sequence, and strand orientation. For elongation blockade in commonly used bacterial systems, targeting the non-template DNA strand is generally more effective than targeting the template strand. Promoter-targeting behavior depends on how the bound complex overlaps the transcriptional machinery.
These effects make guide placement a central determinant of activity: two guides aimed at the same gene can produce very different levels of repression.
Recruitment of repressors in eukaryotic cells
In eukaryotic cells, dCas9 is commonly fused to a transcriptional repression domain. A widely used example is the Krüppel-associated box, or KRAB, domain. It recruits cellular corepressors and chromatin-modifying machinery, helping establish a local environment unfavorable to transcription.
Such systems usually work best when directed near a transcription start site. Effective targeting windows depend on the effector, promoter architecture, cell type, and accuracy of transcription-start-site annotations.
Repression can involve changes to chromatin, including modifications associated with histones. Although these effects are often reversible when the CRISPRi machinery is removed, recovery is not necessarily immediate or complete in every context. Systems specifically designed to create lasting epigenetic silencing are related to conventional CRISPRi but should not be assumed to have the same persistence.
Major implementations
dCas9-based systems
dCas9 is the most established CRISPRi platform. Bacterial applications often use dCas9 without an additional repressor, whereas mammalian applications commonly use dCas9 fused to KRAB or to combinations of repression domains.
Different effector architectures trade off repression strength, molecular size, delivery requirements, and unintended effects. A more potent construct is not necessarily more specific or equally effective in every cell type.
Alternative CRISPR effectors
Catalytically inactive Cas12a and other engineered CRISPR proteins can also support transcriptional repression. Their different PAM requirements and guide architectures provide access to target sites that may be unavailable to a particular Cas9 system.
Some Cas12a-based systems can process arrays containing multiple guide sequences, facilitating simultaneous repression of several targets. Performance remains dependent on the organism, effector design, and genomic context.
Inducible and multiplexed repression
CRISPRi components can be placed under inducible control, allowing gene repression to begin at a chosen time. This is useful when continuous repression would interfere with cell growth or obscure a developmental transition.
Multiplexed systems use several guides to target one or more genes. Multiple guides against a single gene may improve repression, while guides against different genes can reveal genetic interactions. However, competition for a limited pool of effector protein can affect performance.
Applications
Investigating gene function
CRISPRi allows researchers to examine how reduced expression of a gene affects a phenotype. Because it often produces a partial reduction rather than complete loss of function, it is particularly useful for studying dosage-sensitive genes and genes required for cell survival.
Conditional repression can separate a gene’s role in maintaining an established cell state from its role in creating that state. Interpretation still depends on the extent and timing of depletion: a stable protein may remain abundant long after transcription has been reduced.
Pooled genetic screens
In a pooled CRISPRi screen, a population of cells receives a library of guides targeting many genes or regulatory elements. Cells are then exposed to an experimental condition or separated according to a measurable phenotype. Changes in guide abundance identify perturbations associated with growth, survival, or other cellular responses.
Guide identities are commonly quantified using DNA sequencing. Other approaches combine CRISPRi with RNA sequencing, including single-cell measurements, to connect individual perturbations with changes in transcriptional state.
Several guides per target, non-targeting controls, and independent validation help distinguish reproducible biological effects from guide-specific artifacts.
Mapping regulatory DNA
CRISPRi can target noncoding regions, including promoters and enhancers, to test whether they regulate nearby or distant genes. This provides functional evidence that complements measurements of chromatin accessibility and protein binding.
A limitation is that repression may affect a region larger than the precise guide-binding site. A positive result can therefore implicate a regulatory neighborhood without identifying the exact nucleotides responsible for its activity.
Microbial engineering
In microbial biotechnology, CRISPRi can redirect metabolic activity by lowering expression of selected enzymes or regulatory proteins. This can help investigate pathway control or reduce flux through competing pathways.
Unlike deletion of a gene, partial repression can preserve enough activity for growth while changing the distribution of metabolites. Actual outcomes depend on regulatory feedback, growth conditions, and the organism’s physiology.
Comparison with related methods
| Method | Primary action | Typical consequence |
|---|---|---|
| CRISPRi | Inhibits transcription through targeted DNA binding and, often, repressor recruitment | Reduced gene expression without an intended DNA-sequence change |
| Nuclease-based CRISPR knockout | Cuts DNA, followed by cellular repair | Sequence changes that may disrupt gene function |
| [[rna-interference | RNA interference]] | Uses small RNAs to direct transcript silencing, commonly through RNA degradation |
| [[crispr-activation | CRISPR activation]] | Recruits transcriptional activators to regulatory DNA |
CRISPRi acts upstream of messenger RNA production, whereas RNA interference generally acts on RNA after it has been transcribed. Neither approach guarantees complete elimination of the corresponding protein.
Compared with nuclease-based knockout, CRISPRi avoids requiring a targeted DNA break and the resulting DNA repair process. However, it generally requires continued presence of its components to maintain repression. A knockout can remain after the editing machinery has disappeared.
Limitations and interpretation
Variable repression efficiency. Guide sequence, PAM availability, chromatin accessibility, transcription-start-site choice, and effector abundance all influence activity. A weak phenotype may reflect insufficient repression rather than lack of biological importance.
Off-target effects. A guide can direct binding to partially matching sequences elsewhere in the genome. Binding does not always cause detectable repression, but unintended regulation remains possible. Multiple independent guides and complementary validation methods strengthen causal interpretation.
Effects on neighboring genes. Closely spaced or bidirectional promoters can make it difficult to repress one gene without affecting another. In bacteria, targeting a gene within an operon can alter expression of downstream genes, producing a polar effect.
Delayed protein depletion. Reduced transcription does not immediately remove existing RNA or protein. Their turnover rates, together with dilution through cell division, determine how quickly a phenotype appears.
Expression and delivery constraints. Delivering the effector and guide to all relevant cells can be difficult. High expression of CRISPRi components can also impose a cellular burden or cause toxicity in some systems.
Incomplete reversibility and context dependence. Repression is often reversible, but chromatin-mediated effects and the turnover of cellular components can delay recovery. Results obtained in one organism or cell type cannot automatically be transferred to another.
For these reasons, CRISPRi experiments commonly distinguish among target binding, reduced transcript abundance, reduced protein abundance, and the resulting phenotype. Evidence for one does not by itself establish all the others.